Ozempic may be a secret weapon against ADHD
From shedding pounds and treating sleep apnea to lowering the risk of heart attacks, GLP-1s have rapidly evolved…
Weight loss jabs are being linked to ‘Ozempic butt’ — a new drug might stop it
Some people losing weight rapidly have experienced ‘Ozempic butt’ (Picture: Getty Images) It’s no secret that there are…
Trouble Ahead For GLP-1 Drugs As Health Plans Stop Paying
Photo Illustration of the new Wegovy semaglutide tablets with injectable prescription weight loss medicines, Ozempic, Victoza and Wegovy.…
The lesser-known health reasons a doctor can refuse you for Mounjaro or Wegovy
Prescribers need to be sure the drugs will be safe and effective (Picture: Getty Images) For many Brits…
Semaglutide and Ozempic-like drugs may improve kidney disease outcomes
Semaglutide, a medication commonly sold as Ozempic or Wegovy, is typically associated with weight loss. But it can…
Dermatologist explains what happens to your body after you take Melanotan II
A dermatologist has warned that people are putting their bodies at serious risk by taking a tanning drug…
Taking Ozempic? New Study Explains Why Pairing It With Exercise Is Important For Your Muscles
Weight loss medications such as Ozempic have truly changed the way obesity is treated. Ozempic has semaglutide, which…
Can Ozempic Treat Alcoholism? Here’s What You Should Know
Semaglutide (the active ingredient in Ozempic and Wegovy) and other GLP-1 medications have rapidly become some of the…
Novo Nordisk will slash Ozempic price for some, ‘aligning’ with generics – National
Some Canadians will be able to buy brand-name GLP-1 drug Ozempic at a reduced price, Danish drugmaker Novo…
GLP-1s are fueling a rise of a bizarre, rare ear disorder
Welcome to The Thin Line, The New York Post’s series about the darker side of GLP-1 drugs. Though…
The Deadly Venom Behind Ozempic—and Why the Miracle Drug Should Have Never Worked
When scientists first discovered the insulin secretion effects of gut hormone GLP-1 in the 1980s, it seemed like…
Brazil approves first generic semaglutide pen after Ozempic patent expiry
SAO PAULO, May 26 (Reuters) – Brazil’s health regulator Anvisa said on Tuesday it had approved EMS’s Ozivy,…